Radostina C.
- Country
- Bulgaria
- Department
- n/a
Research Overview
- Efficacy and Safety of Early Depemokimab Initiation as Add-on Therapy in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
- Phase 3 Study of GB-0895 Adjunctive Therapy in Adults and Adolescents with Severe Uncontrolled Asthma
- Efficacy, Safety, and Tolerability of Beclometasone Dipropionate, Formoterol Fumarate, and Glycopyrronium Bromide in COPD: A Randomized, Double-Blind Study
Data & Insights
Has run more than one trial at 36 of 200 partner sites.
Specializations
Respiratory Medicine
The investigator specializes in treating and researching respiratory conditions, with particular expertise in chronic obstructive pulmonary disease (COPD) and mild asthma.
- Pulmonary Function Assessment
- Inhaler Therapy Optimization
- Respiratory Disease Management
Their work focuses on evaluating innovative inhalation therapies and delivery systems for respiratory conditions.
Therapeutic Innovation
The investigator has particular interest in studying pressurized metered dose inhalers and their applications in respiratory medicine.
- Drug Delivery Systems
- Inhalation Technology
- Treatment Efficacy Assessment
Their research encompasses the evaluation of different propellant systems and their impact on therapeutic effectiveness.
Clinical Assessment
The investigator conducts comprehensive evaluations of lung function and respiratory treatment responses.
- Respiratory Function Testing
- Treatment Safety Analysis
- Clinical Efficacy Studies
Their work includes assessment of pre-dose lung function and comparative analysis of different therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.